These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31319102)

  • 1. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study.
    Dua S; Ruiz-Garcia M; Bond S; Durham SR; Kimber I; Mills C; Roberts G; Skypala I; Wason J; Ewan P; Boyle R; Clark A
    J Allergy Clin Immunol; 2019 Dec; 144(6):1584-1594.e2. PubMed ID: 31319102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled Trial.
    Dua S; Ruiz-Garcia M; Bond S; Dowey J; Durham SR; Kimber I; Mills C; Roberts G; Skypala I; Wason J; Ewan P; Boyle RJ; Clark A
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2404-2413.e1. PubMed ID: 35623576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy.
    Wensing M; Penninks AH; Hefle SL; Koppelman SJ; Bruijnzeel-Koomen CA; Knulst AC
    J Allergy Clin Immunol; 2002 Dec; 110(6):915-20. PubMed ID: 12464959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
    Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
    JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
    Anagnostou K; Islam S; King Y; Foley L; Pasea L; Bond S; Palmer C; Deighton J; Ewan P; Clark A
    Lancet; 2014 Apr; 383(9925):1297-1304. PubMed ID: 24485709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF; Du Toit G; Douiri A; Radulovic S; Stephens A; Turcanu V; Lack G
    J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis.
    Patel N; Adelman DC; Anagnostou K; Baumert JL; Blom WM; Campbell DE; Chinthrajah RS; Mills ENC; Javed B; Purington N; Remington BC; Sampson HA; Smith AD; Yarham RAR; Turner PJ
    J Allergy Clin Immunol; 2021 Jun; 147(6):2249-2262.e7. PubMed ID: 33571537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender, prick test size and rAra h 2 sIgE level may predict the eliciting dose in patients with peanut allergy: Evidence from the Mirabel survey.
    Elegbede CF; Papadopoulos A; Just J; Moneret-Vautrin DA; Deschildre A; Crépet A
    Clin Exp Allergy; 2019 May; 49(5):677-689. PubMed ID: 30689235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible.
    Glaumann S; Nopp A; Johansson SG; Borres MP; Nilsson C
    PLoS One; 2013; 8(1):e53465. PubMed ID: 23326435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint transcriptomic and cytometric study of children with peanut allergy reveals molecular and cellular cross talk in reaction thresholds.
    Zhang L; Chun Y; Arditi Z; Grishina G; Lo T; Wisotzkey K; Agashe C; Grishin A; Wang J; Sampson HA; Sicherer S; Berin MC; Bunyavanich S
    J Allergy Clin Immunol; 2024 Jun; 153(6):1721-1728. PubMed ID: 38272374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical thresholds to egg, hazelnut, milk and peanut: results from a single-center study using standardized challenges.
    Eller E; Hansen TK; Bindslev-Jensen C
    Ann Allergy Asthma Immunol; 2012 May; 108(5):332-6. PubMed ID: 22541404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.
    Arkwright PD; MacMahon J; Koplin J; Rajput S; Cross S; Fitzsimons R; Davidson N; Deshpande V; Rao N; Lumsden C; Lacy D; Allen KJ; Vance G; Mwenechanya J; Fox AT; Erlewyn-Lajeunesse M; Mistry H; Hourihane JO
    Pediatr Allergy Immunol; 2018 Nov; 29(7):754-761. PubMed ID: 30022517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupin allergy in peanut-allergic children and teenagers.
    Shaw J; Roberts G; Grimshaw K; White S; Hourihane J
    Allergy; 2008 Mar; 63(3):370-3. PubMed ID: 18028245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Marrs T; Flohr C; Perkin MR
    Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.